Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier Versteeg

Showing results (61-70 of 139) with videos related to

Pageof 14
Sort By:
Genes, Chromosomes & Cancer|February 25, 2009
Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor developmentEdoardo Missiaglia, Joanna Selfe, Mohamed Hamdi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 28, 2012
Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growthFieke Lamers, Linda Schild, Ilona J M den Hartog, et al.
Genes, Chromosomes & Cancer|October 29, 2011
Copy number defects of G1-cell cycle genes in neuroblastoma are frequent and correlate with high expression of E2F target genes and a poor prognosisJan J Molenaar, Jan Koster, Marli E Ebus, et al.
Journal of Cellular Biochemistry|May 31, 2012
Arrangement of nuclear structures is not transmitted through mitosis but is identical in sister cellsDarya Yu Orlova, Lenka Stixová, Stanislav Kozubek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2012
Mutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancerKristel Kemper, Miranda Versloot, Katherine Cameron, et al.
Cancer Research|April 4, 2014
Selection of personalized patient therapy through the use of knowledge-based computational models that identify tumor-driving signal transduction pathwaysWim Verhaegh, Henk van Ooijen, Márcia A Inda, et al.
Molecular Cancer|July 10, 2013
ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumoursAnnica Wilzén, Cecilia Krona, Baldur Sveinbjörnsson, et al.
Cancer Research|August 18, 2018
RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in NeuroblastomaThomas F Eleveld, Linda Schild, Jan Koster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expressionTalitha de Haas, Nancy Hasselt, Dirk Troost, et al.
Aging Cell|January 8, 2023
FOXO3A-short is a novel regulator of non-oxidative glucose metabolism associated with human longevityEvan E Santo, Rasmus Ribel-Madsen, Peter J Stroeken, et al.
Pageof 14

Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
Genes, Chromosomes & Cancer|February 25, 2009
Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor developmentEdoardo Missiaglia, Joanna Selfe, Mohamed Hamdi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 28, 2012
Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growthFieke Lamers, Linda Schild, Ilona J M den Hartog, et al.
Genes, Chromosomes & Cancer|October 29, 2011
Copy number defects of G1-cell cycle genes in neuroblastoma are frequent and correlate with high expression of E2F target genes and a poor prognosisJan J Molenaar, Jan Koster, Marli E Ebus, et al.
Journal of Cellular Biochemistry|May 31, 2012
Arrangement of nuclear structures is not transmitted through mitosis but is identical in sister cellsDarya Yu Orlova, Lenka Stixová, Stanislav Kozubek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2012
Mutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancerKristel Kemper, Miranda Versloot, Katherine Cameron, et al.
Cancer Research|April 4, 2014
Selection of personalized patient therapy through the use of knowledge-based computational models that identify tumor-driving signal transduction pathwaysWim Verhaegh, Henk van Ooijen, Márcia A Inda, et al.
Molecular Cancer|July 10, 2013
ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumoursAnnica Wilzén, Cecilia Krona, Baldur Sveinbjörnsson, et al.
Cancer Research|August 18, 2018
RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in NeuroblastomaThomas F Eleveld, Linda Schild, Jan Koster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expressionTalitha de Haas, Nancy Hasselt, Dirk Troost, et al.
Aging Cell|January 8, 2023
FOXO3A-short is a novel regulator of non-oxidative glucose metabolism associated with human longevityEvan E Santo, Rasmus Ribel-Madsen, Peter J Stroeken, et al.
Pageof 14